Biobanking Market Size And Growth | Industry Report by 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Biobanking Market Size Analysis

Global Biobanking Market Introduction
By Specimen Type
1. Introduction
  1. Specimen Type By Value
2. Blood Products
  1. By Value
3. Solid Tissue
  1. By Value
4. Cell Lines
  1. By Value
5. Nucleic Acid
  1. By Value
6. Others
  1. By Value
By Type of Biobank
1. Introduction
  1. Type of Biobank By Value
2. Population-Based Biobanks
  1. By Value
3. Disease-Oriented Biobanks
  1. By Value
By Ownership
1. Introduction
  1. Ownership By Value
2. National/Regional Agency
  1. By Value
3. Non-Profit Organization
  1. By Value
4. Universities
  1. By Value
5. Private Organization
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Therapeutic
  1. By Value
3. Research
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academic Institutions
  1. By Value
3. Pharma & Biotech Companies
  1. By Value

North America Market Analysis

Introduction
By Specimen Type
1. Introduction
  1. Specimen Type By Value
2. Blood Products
  1. By Value
3. Solid Tissue
  1. By Value
4. Cell Lines
  1. By Value
5. Nucleic Acid
  1. By Value
6. Others
  1. By Value
By Type of Biobank
1. Introduction
  1. Type of Biobank By Value
2. Population-Based Biobanks
  1. By Value
3. Disease-Oriented Biobanks
  1. By Value
By Ownership
1. Introduction
  1. Ownership By Value
2. National/Regional Agency
  1. By Value
3. Non-Profit Organization
  1. By Value
4. Universities
  1. By Value
5. Private Organization
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Therapeutic
  1. By Value
3. Research
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academic Institutions
  1. By Value
3. Pharma & Biotech Companies
  1. By Value
U.S.
1. By Specimen Type
  1. Introduction
    1. Specimen Type By Value
  2. Blood Products
    1. By Value
  3. Solid Tissue
    1. By Value
  4. Cell Lines
    1. By Value
  5. Nucleic Acid
    1. By Value
  6. Others
    1. By Value
2. By Type of Biobank
  1. Introduction
    1. Type of Biobank By Value
  2. Population-Based Biobanks
    1. By Value
  3. Disease-Oriented Biobanks
    1. By Value
3. By Ownership
  1. Introduction
    1. Ownership By Value
  2. National/Regional Agency
    1. By Value
  3. Non-Profit Organization
    1. By Value
  4. Universities
    1. By Value
  5. Private Organization
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Therapeutic
    1. By Value
  3. Research
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Academic Institutions
    1. By Value
  3. Pharma & Biotech Companies
    1. By Value
Canada

Europe Market Analysis

Introduction
By Specimen Type
1. Introduction
  1. Specimen Type By Value
2. Blood Products
  1. By Value
3. Solid Tissue
  1. By Value
4. Cell Lines
  1. By Value
5. Nucleic Acid
  1. By Value
6. Others
  1. By Value
By Type of Biobank
1. Introduction
  1. Type of Biobank By Value
2. Population-Based Biobanks
  1. By Value
3. Disease-Oriented Biobanks
  1. By Value
By Ownership
1. Introduction
  1. Ownership By Value
2. National/Regional Agency
  1. By Value
3. Non-Profit Organization
  1. By Value
4. Universities
  1. By Value
5. Private Organization
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Therapeutic
  1. By Value
3. Research
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academic Institutions
  1. By Value
3. Pharma & Biotech Companies
  1. By Value
U.K.
1. By Specimen Type
  1. Introduction
    1. Specimen Type By Value
  2. Blood Products
    1. By Value
  3. Solid Tissue
    1. By Value
  4. Cell Lines
    1. By Value
  5. Nucleic Acid
    1. By Value
  6. Others
    1. By Value
2. By Type of Biobank
  1. Introduction
    1. Type of Biobank By Value
  2. Population-Based Biobanks
    1. By Value
  3. Disease-Oriented Biobanks
    1. By Value
3. By Ownership
  1. Introduction
    1. Ownership By Value
  2. National/Regional Agency
    1. By Value
  3. Non-Profit Organization
    1. By Value
  4. Universities
    1. By Value
  5. Private Organization
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Therapeutic
    1. By Value
  3. Research
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Academic Institutions
    1. By Value
  3. Pharma & Biotech Companies
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Specimen Type
1. Introduction
  1. Specimen Type By Value
2. Blood Products
  1. By Value
3. Solid Tissue
  1. By Value
4. Cell Lines
  1. By Value
5. Nucleic Acid
  1. By Value
6. Others
  1. By Value
By Type of Biobank
1. Introduction
  1. Type of Biobank By Value
2. Population-Based Biobanks
  1. By Value
3. Disease-Oriented Biobanks
  1. By Value
By Ownership
1. Introduction
  1. Ownership By Value
2. National/Regional Agency
  1. By Value
3. Non-Profit Organization
  1. By Value
4. Universities
  1. By Value
5. Private Organization
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Therapeutic
  1. By Value
3. Research
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academic Institutions
  1. By Value
3. Pharma & Biotech Companies
  1. By Value
China
1. By Specimen Type
  1. Introduction
    1. Specimen Type By Value
  2. Blood Products
    1. By Value
  3. Solid Tissue
    1. By Value
  4. Cell Lines
    1. By Value
  5. Nucleic Acid
    1. By Value
  6. Others
    1. By Value
2. By Type of Biobank
  1. Introduction
    1. Type of Biobank By Value
  2. Population-Based Biobanks
    1. By Value
  3. Disease-Oriented Biobanks
    1. By Value
3. By Ownership
  1. Introduction
    1. Ownership By Value
  2. National/Regional Agency
    1. By Value
  3. Non-Profit Organization
    1. By Value
  4. Universities
    1. By Value
  5. Private Organization
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Therapeutic
    1. By Value
  3. Research
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Academic Institutions
    1. By Value
  3. Pharma & Biotech Companies
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Specimen Type
1. Introduction
  1. Specimen Type By Value
2. Blood Products
  1. By Value
3. Solid Tissue
  1. By Value
4. Cell Lines
  1. By Value
5. Nucleic Acid
  1. By Value
6. Others
  1. By Value
By Type of Biobank
1. Introduction
  1. Type of Biobank By Value
2. Population-Based Biobanks
  1. By Value
3. Disease-Oriented Biobanks
  1. By Value
By Ownership
1. Introduction
  1. Ownership By Value
2. National/Regional Agency
  1. By Value
3. Non-Profit Organization
  1. By Value
4. Universities
  1. By Value
5. Private Organization
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Therapeutic
  1. By Value
3. Research
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academic Institutions
  1. By Value
3. Pharma & Biotech Companies
  1. By Value
UAE
1. By Specimen Type
  1. Introduction
    1. Specimen Type By Value
  2. Blood Products
    1. By Value
  3. Solid Tissue
    1. By Value
  4. Cell Lines
    1. By Value
  5. Nucleic Acid
    1. By Value
  6. Others
    1. By Value
2. By Type of Biobank
  1. Introduction
    1. Type of Biobank By Value
  2. Population-Based Biobanks
    1. By Value
  3. Disease-Oriented Biobanks
    1. By Value
3. By Ownership
  1. Introduction
    1. Ownership By Value
  2. National/Regional Agency
    1. By Value
  3. Non-Profit Organization
    1. By Value
  4. Universities
    1. By Value
  5. Private Organization
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Therapeutic
    1. By Value
  3. Research
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Academic Institutions
    1. By Value
  3. Pharma & Biotech Companies
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Specimen Type
1. Introduction
  1. Specimen Type By Value
2. Blood Products
  1. By Value
3. Solid Tissue
  1. By Value
4. Cell Lines
  1. By Value
5. Nucleic Acid
  1. By Value
6. Others
  1. By Value
By Type of Biobank
1. Introduction
  1. Type of Biobank By Value
2. Population-Based Biobanks
  1. By Value
3. Disease-Oriented Biobanks
  1. By Value
By Ownership
1. Introduction
  1. Ownership By Value
2. National/Regional Agency
  1. By Value
3. Non-Profit Organization
  1. By Value
4. Universities
  1. By Value
5. Private Organization
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Therapeutic
  1. By Value
3. Research
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academic Institutions
  1. By Value
3. Pharma & Biotech Companies
  1. By Value
Brazil
1. By Specimen Type
  1. Introduction
    1. Specimen Type By Value
  2. Blood Products
    1. By Value
  3. Solid Tissue
    1. By Value
  4. Cell Lines
    1. By Value
  5. Nucleic Acid
    1. By Value
  6. Others
    1. By Value
2. By Type of Biobank
  1. Introduction
    1. Type of Biobank By Value
  2. Population-Based Biobanks
    1. By Value
  3. Disease-Oriented Biobanks
    1. By Value
3. By Ownership
  1. Introduction
    1. Ownership By Value
  2. National/Regional Agency
    1. By Value
  3. Non-Profit Organization
    1. By Value
  4. Universities
    1. By Value
  5. Private Organization
    1. By Value
4. By Application
  1. Introduction
    1. Application By Value
  2. Therapeutic
    1. By Value
  3. Research
    1. By Value
5. By End-User
  1. Introduction
    1. End-User By Value
  2. Academic Institutions
    1. By Value
  3. Pharma & Biotech Companies
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Biobanking Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

BioIVT & Elevating Science
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Geneticist Inc
Firalis S.A
AMS Biotechnology Ltd. (AMSBIO LLC)
US Biolab Corporation, Inc
ProteoGenex, Inc.
Cureline, Inc.
Bay Biosciences LLC
CTI Biotech
Boca Biolistics
Illumina Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment